We hypothesized that the low expression of MARCH8 in lung cancer could be due to the regulation of aberrant transcription factors or epigenetic regulation, which may also be a key factor in the role of MARCH8 in human lung cancer. The gene discussed is MARCHF8; the disease is lung cancer.